Broshy Eran
- SEC CIK
- 0001256230
In the past year, 2 open-market sale filings worth $1.40M and no purchases.
Current role at each company
- CERT Certara, Inc.Director, Other: Chairmanas of May 15, 2026
- TBPH Theravance Biopharma, Inc.Directoras of Dec 1, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.40M
- 2 filings
- Net
- −$1.40M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Broshy Eran as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TBPH Theravance Biopharma, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 (view filing) | Nov 26 | 5 days | Broshy EranDirector | SSale | −29.5K | $20.00 | −$590.0K | −39.8%44.7K after | 2 lots10b5-1 |
| Nov 14, 2025 (view filing) | Nov 11 | 3 days | Broshy EranDirector | SSale | −45.0K | $17.98 | −$809.3K | −42.8%60.2K after | Amended3 lots |
CERT Certara, Inc.
Director, Other: Chairman1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2023 (view filing) | Aug 21-22 | 2 days | Broshy EranDirector | PPurchase | +5.00K | $15.81 | +$79.1K | +53.4%14.4K after | 2 lots |